BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q, Cai BY, Zhu LX, Xin X, Wang X, An ZM, Li S, Hu YY, Feng Q. Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. Life Sci 2020;261:118457. [PMID: 32961235 DOI: 10.1016/j.lfs.2020.118457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Du Y, Li DX, Lu DY, Zhang R, Zheng XX, Xu BJ, Zhao YL, Ji S, Guo MZ, Wang L, Tang DQ. Morus alba L. water extract changes gut microbiota and fecal metabolome in mice induced by high-fat and high-sucrose diet plus low-dose streptozotocin. Phytother Res 2022. [PMID: 35129235 DOI: 10.1002/ptr.7343] [Reference Citation Analysis]
2 Chen J, Ding X, Wu R, Tong B, Zhao L, Lv H, Meng X, Liu Y, Ren B, Li J, Jian T, Li W. Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition. J Agric Food Chem 2021;69:14176-91. [PMID: 34783554 DOI: 10.1021/acs.jafc.1c05596] [Reference Citation Analysis]
3 Wu R, Zhou L, Chen Y, Ding X, Liu Y, Tong B, Lv H, Meng X, Li J, Jian T, Chen J. Sesquiterpene glycoside isolated from loquat leaf targets gut microbiota to prevent type 2 diabetes mellitus in db/db mice. Food Funct . [DOI: 10.1039/d1fo03646g] [Reference Citation Analysis]
4 Ma J, Wang J, Xu L, Liu Y, Gu J. The beneficial effects of genetically engineered Escherichia coli Nissle 1917 in obese C57BL/6J mice. Int J Obes. [DOI: 10.1038/s41366-022-01073-8] [Reference Citation Analysis]
5 Lanthier N, Rodriguez J, Nachit M, Hiel S, Trefois P, Neyrinck AM, Cani PD, Bindels LB, Thissen JP, Delzenne NM. Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Sci Rep 2021;11:659. [PMID: 33436764 DOI: 10.1038/s41598-020-79718-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Dai Y, He H, Li S, Yang L, Wang X, Liu Z, An Z. Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:622589. [PMID: 33664710 DOI: 10.3389/fendo.2020.622589] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang Y, Wei X, Sun Q, Qian W, Liu X, Li J, Long Y, Wan X. Different Types and Functional Effects of Probiotics on Human Health through Regulating Glucose Homeostasis. J Agric Food Chem 2021;69:14781-91. [PMID: 34855398 DOI: 10.1021/acs.jafc.1c04291] [Reference Citation Analysis]
8 Du L, Wang Q, Ji S, Sun Y, Huang W, Zhang Y, Li S, Yan S, Jin H. Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice. Front Cell Infect Microbiol 2022;12:729940. [DOI: 10.3389/fcimb.2022.729940] [Reference Citation Analysis]
9 Wang C, Hu HJ, Dong QQ, Huang R, Zhao W, Song YJ, Li ZY, Wang N, Zhang TC, Luo XG. Enhancing bile tolerance of Lactobacilli is involved in the hypolipidemic effects of liraglutide. Biosci Biotechnol Biochem 2021;85:1395-404. [PMID: 33784390 DOI: 10.1093/bbb/zbab053] [Reference Citation Analysis]
10 El-shafey M, El-agawy MSE, Eldosoky M, Ebrahim HA, Elsherbini DMA, El-sherbiny M, Asseri SM, Elsherbiny NM. Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis. Front Endocrinol 2022;13:862394. [DOI: 10.3389/fendo.2022.862394] [Reference Citation Analysis]